Xue, Aiqun <br/><br/>
Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.  [electronic resource] 

 -  The international journal of biochemistry & cell biology   
 - 1731-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-5875 
<br/><br/><label>Standard No.: </label>10.1016/j.biocel.2009.03.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--enzymology<br/>Apoptosis--drug effects<br/>Caspase 3--metabolism<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Down-Regulation--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Extracellular Signal-Regulated MAP Kinases--antagonists & inhibitors<br/>Humans<br/>MAP Kinase Signaling System--drug effects<br/>Pancreatic Neoplasms--enzymology<br/>Plasminogen Activator Inhibitor 2--metabolism<br/>RNA, Small Interfering--metabolism<br/>Receptors, Urokinase Plasminogen Activator--metabolism<br/>Urokinase-Type Plasminogen Activator--metabolism<br/>p38 Mitogen-Activated Protein Kinases--antagonists & inhibitors